Our speakers will be discussing how they used a Design Thinking Methodology approach for insight and prototype generation. People with both Type 1 and Type 2 diabetes were invited to co-create digital/technology solutions to support them in their daily diabetes management as a means to enhance patient engagement as part of a virtual clinical trial. The insights and recommendations gained from this established patient advisory panel can be further leveraged across other therapeutic areas that will ultimately incorporate the use of digital clinical applications. This engagement produced several ideal prototypes that would:
Explore related content and topics
Fact Sheet
First-in-Human Drug Evaluation at PRA Health Sciences & The Revised EMA Guideline on Early Clinical Trials
In July 2017, the European Medicines Agency (EMA) published its revised guidance on first-in-human (FIH) and early clinical trials. The revision…
Poster
Retrospective Analysis of the Effects of Protocol Design on Completion Rates in Phase 1 Studies in Subjects with Stable Schizophrenia
Subject attrition from randomized Schizophrenia trials is a significant problem and has been found in meta-analysis to be as high as 76% (Robinowitz…
Poster
A Retrospective Analysis of the Effects of Protocol Design on Completion Rates in Outpatient Clinical Trials in Subjects with Schizophrenia or Schizoaffective Disorder
Subject attrition from randomized Schizophrenia trials is a significant problem and has been found in a meta-analysis to be as high as 76%. The…